Vyepti (eptinezumab or eptinezumab-jjmr) is a medication that's used to prevent migraines in adults. The dose is given as an infusion through the veins at a provider's office or clinic every 3 months. Side effects aren't common, but they can include common cold symptoms, itching, and flushing. Vyepti (eptinezumab) is only available as a brand name.
Prevention of migraines in adults
Vyepti (eptinezumab) is a calcitonin gene-related peptide (CGRP) receptor blocker. It's a monoclonal antibody that blocks a protein in the brain and nervous system called CGRP. CGRP is thought to be involved with migraines and causing pain. By blocking CGRP, Vyepti (eptinezumab) helps block migraines from happening.
Source: DailyMed
Side effects that you should report to your care team as soon as possible:
Side effects that usually do not require medical attention (report these to your care team if they continue or are bothersome):
Given as an infusion through the veins (IV)
Needs to be given by a healthcare provider
Hasn't been studied well enough in children or in older adults, so it's not completely known how well the medication works for them
Discuss with your provider about where you can get Vyepti (eptinezumab), what to expect during the infusions, and any other questions you might have about treatment. The manufacturer of Vyepti (eptinezumab) also has helpful information, resources, and tips to get you started for your infusion.
Mark your infusion appointments on your calendar to make sure you don't miss any doses of Vyepti (eptinezumab).
Drink plenty of water before your Vyepti (eptinezumab) infusion appointment to stay well hydrated.
Plan for your Vyepti (eptinezumab) infusion appointments accordingly. The infusion itself takes about 30 minutes, but give yourself some time beforehand to check in. Your provider might also need some time to finish preparing the medication for your infusion.
Tell your provider if you're pregnant, thinking of becoming pregnant, or planning to breastfeed. We don't know whether Vyepti (eptinezumab) can cause harm to unborn babies, though studies show that it didn't in animals. It also isn't known whether the medication passes into breast milk.
Talk to your provider if you have a migraine in between your Vyepti (eptinezumab) infusion appointments. They can recommend strategies to manage your migraines, including avoiding triggers, medications to ease the headache quickly, and alternative therapies like acupressure.
Vyepti (eptinezumab) can cause some serious health issues. This risk may be even higher for certain groups. If this worries you, talk to your doctor or pharmacist about other options.
Vyepti (eptinezumab) can cause allergic reactions, such as hives, flushing in the face, rash, shortness of breath, and angioedema (swelling of the skin or lips). Most allergic reactions happen during the infusion and aren't serious. But it's possible that they can be serious and life-threatening (e.g., swelling of face and throat, sudden low blood pressure, dizziness, fainting).
Call your nurse over right away if you get any of these symptoms during your infusion. Call 911 as soon as possible if you have these symptoms after your Vyepti (eptinezumab) infusion and you've left the office or clinic center.
The typical dose is 100 mg or 300 mg infused through the veins (intravenously or IV) once every 3 months.
Prevention of migraines in adults
By signing up, I agree to GoodRx's Terms and Privacy Policy, and to receive marketing messages from GoodRx.
Ashina, M., et al. (2020). Eptinezumab in episodic migraine: A randomized, double-blind, placebo-controlled study (PROMISE-1). Cephalalgia.
Banks, J. (n.d.). CGRP: What you need to know. National Headache Foundation.
Berger, A. A., et al. (2022). Eptinezumab-jjmr, a humanized monoclonal specific to Calcitonin Gene Related Peptide, for the preventive treatment of migraine in adults. Health Psychology Research.
Datta, A., et al. (2021). A review of eptinezumab use in migraine. Cureus.
Lipton, R. B., et al. (2020). Efficacy and safety of eptinezumab in patients with chronic migraine: PROMISE-2. Neurology.
Lundbeck Pharmaceuticals LLC. (2022). Vyepti- eptinezumab-jjmr injection [package insert]. DailyMed.
Lundbeck Seattle BioPharmaceuticals, Inc. (n.d.). Designed to help prevent migraine attacks.
Lundbeck Seattle BioPharmaceuticals, Inc. (n.d.). Find an infusion location that's right for you.
Lundbeck Seattle BioPharmaceuticals, Inc. (n.d.). Getting ready for Vyepti.
Lundbeck Seattle BioPharmaceuticals, Inc. (n.d.). People on Vyepti had more migraine-free days.
MedlinePlus. (2022). Angioedema.
Woods, R. H. (2022). Alopecia signals associated with calcitonin gene-related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study. Pharmacotherapy.
Research prescriptions and over-the-counter medications from A to Z, compare drug prices, and start saving.